PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 172 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $32,888,000 | -8.2% | 1,377,236 | +3.1% | 0.02% | -10.5% |
| Q3 2019 | $35,821,000 | +16.3% | 1,335,590 | +17.6% | 0.02% | +18.8% |
| Q2 2019 | $30,809,000 | -7.3% | 1,135,590 | +18.5% | 0.02% | -11.1% |
| Q1 2019 | $33,242,000 | +59.8% | 957,990 | -10.1% | 0.02% | +38.5% |
| Q4 2018 | $20,808,000 | +13.8% | 1,066,000 | +55.2% | 0.01% | +44.4% |
| Q3 2018 | $18,287,000 | -25.7% | 686,700 | +5.4% | 0.01% | -30.8% |
| Q2 2018 | $24,618,000 | +81.0% | 651,800 | +13.1% | 0.01% | +85.7% |
| Q2 2016 | $13,601,000 | -49.3% | 576,318 | -56.2% | 0.01% | -50.0% |
| Q1 2016 | $26,842,000 | -40.2% | 1,315,812 | +50.8% | 0.01% | -39.1% |
| Q4 2015 | $44,885,000 | -14.7% | 872,401 | -29.3% | 0.02% | -11.5% |
| Q3 2015 | $52,623,000 | -25.1% | 1,234,701 | -20.0% | 0.03% | -18.8% |
| Q2 2015 | $70,279,000 | +23.5% | 1,542,901 | +3.0% | 0.03% | +23.1% |
| Q1 2015 | $56,887,000 | +19.1% | 1,498,601 | -11.2% | 0.03% | +18.2% |
| Q4 2014 | $47,771,000 | +5.3% | 1,686,827 | -6.0% | 0.02% | +4.8% |
| Q3 2014 | $45,373,000 | -4.9% | 1,794,801 | +9.7% | 0.02% | 0.0% |
| Q2 2014 | $47,730,000 | +72.3% | 1,635,701 | +52.9% | 0.02% | +61.5% |
| Q1 2014 | $27,705,000 | +72.8% | 1,069,701 | +71.8% | 0.01% | +62.5% |
| Q4 2013 | $16,037,000 | +13.3% | 622,801 | +17.7% | 0.01% | 0.0% |
| Q3 2013 | $14,159,000 | +22.1% | 529,301 | +12.2% | 0.01% | +14.3% |
| Q2 2013 | $11,595,000 | – | 471,901 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |